3 Recruiting Carcinoma Phase 2 Clinical Trials
Active phase 2 studies for carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Carcinoma studiesPhase 2 Studies for Carcinoma
🔵 Active, Not Recruiting Phase2
Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib
📍 Research Site — La Jolla, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
📍 Clearview Cancer Institute (Crestwood) — Huntsville, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy
📍 Providence Medical Foundation -Fullerton — Fullerton, California
View Study & Checklist ➔